Evidence map›Paper›PMID 39302559›Full record

ArticleBreast cancer (Tokyo, Japan)2024

Correction: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM).

Takahiro Nakayama, Naoki Niikura, Takashi Yamanaka, Mitsugu Yamamoto, Kazuo Matsuura, Kenichi Inoue, Sachiko Takahara, Hironori Nomura, Shosuke Kita, Miki Yamaguchi and 10 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Breast cancer (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Takahiro NakayamaDepartment of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan.
Naoki NiikuraDepartment of Breast Oncology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan. nniikura@tokai.ac.jp.
Takashi YamanakaDepartment of Breast Surgery and Oncology, Kanagawa Cancer Center, Kanagawa, Japan.
Mitsugu YamamotoDepartment of Breast Oncology, Hokkaido Cancer Center, Hokkaido, Japan.
Kazuo MatsuuraDepartment of Breast Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
Kenichi InoueDivision of Breast Oncology, Saitama Cancer Center, Saitama, Japan.
Sachiko TakaharaDepartment of Breast Surgery, Kitano Hospital, Osaka, Japan.
Hironori NomuraFirst Department of Surgery, University of the Ryukyus Hospital, Okinawa, Japan.
Shosuke KitaDepartment of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Miki YamaguchiDepartment of Breast Surgery, JCHO Kurume General Hospital, Fukuoka, Japan.
Tomoyuki ArugaDepartment of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Nobuhiro ShibataCancer Treatment Center, Kansai Medical University Hospital, Osaka, Japan.
Akihiko ShimomuraDepartment of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
Yuri OzakiDepartment of Breast Oncology, Aichi Cancer Center, Aichi, Japan.
Shuji SakaiDepartment of Diagnostic Imaging and Nuclear Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Daisuke TakiguchiOncology Medical Science Department I, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
Takehiko TakataOncology Medical Science Department I, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
Armin BastanfardOncology Medical Science Department I, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
Kazuhito ShiosakaiData Intelligence Department, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
Junji TsurutaniAdvanced Cancer Translational Research Institute, Showa University, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39302559
PMCPMC11489219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.